HAVCR1 and acute kidney injury: This is consistent with our experimental results, which confirm SESN2 as a protective factor against kidney injury and link SESN2 to KIM-1 via AMPK, revealing the novel SESN2/AMPK/KIM-1 pathway and offering a new idea for IRI-AKI treatment.